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Background:Muscle fromheterozygous and homozygous T4826I-RYR1MH-susceptiblemice is investigated for biochem-
ical and cellular abnormalities.
Results:T4826I-RYR1 gene dose determines severity of [Ca2]rest, mitochondrial, EC coupling, andCa2 channel impairments.
Conclusion: T4826I-RYR1 channel dysfunction is regulated in vivo but imparts susceptibility to environmental triggers.
Significance: T4826I-RYR1 is sufficient to confer MHS strongly dependent on gene dose.
Malignant hyperthermia susceptibility (MHS) is primarily
conferred by mutations within ryanodine receptor type 1
(RYR1). Here we address how theMHSmutation T4826I within
the S4-S5 linker influences excitation-contraction coupling and
resting myoplasmic Ca2 concentration ([Ca2]rest) in flexor
digitorum brevis (FDB) and vastus lateralis prepared from
heterozygous (Het) and homozygous (Hom) T4826I-RYR1
knock-in mice (Yuen, B. T., Boncompagni, S., Feng, W., Yang,
T., Lopez, J. R., Matthaei, K. I., Goth, S. R., Protasi, F., Franzini-
Armstrong, C., Allen, P. D., and Pessah, I. N. (2011) FASEB J.
doi:22131268). FDB responses to electrical stimuli and acute
halothane (0.1%, v/v) exposure showed a rank order of Hom >>
Het >> WT. Release of Ca2 from the sarcoplasmic reticulum
and Ca2 entry contributed to halothane-triggered increases in
[Ca2]rest in Hom FDBs and elicited pronounced Ca2 oscilla-
tions in 30% of FDBs tested. Genotype contributed signifi-
cantly elevated [Ca2]rest (Hom > Het > WT) measured in vivo
using ion-selective microelectrodes. Het and Hom oxygen con-
sumption ratesmeasured in intactmyotubes using the Seahorse
Bioscience (Billerica,MA) flux analyzer andmitochondrial con-
tent measured with MitoTracker were lower thanWT, whereas
total cellular calpain activity was higher thanWT.Musclemem-
branes did not differ in RYR1 expression nor in Ser2844 phosphor-
ylation among the genotypes. Single channel analysis showed
highly divergent gating behavior with Hom and WT favoring
open and closed states, respectively, whereas Het exhibited het-
erogeneous gating behaviors. [3H]Ryanodine binding analysis
revealed a gene dose influence on binding density and regula-
tion by Ca2, Mg2, and temperature. Pronounced abnormali-
ties inherent in T4826I-RYR1 channels confer MHS and pro-
mote basal disturbances of excitation-contraction coupling,
[Ca2]rest, and oxygen consumption rates. Considering that
both Het and Hom T4826I-RYR1 mice are viable, the remarka-
ble isolated single channel dysfunction mediated through this
mutation in S4-S5 cytoplasmic linker must be highly regulated
in vivo.
Fulminant malignant hyperthermia (MH)3 is a pharmacoge-
netic, life-threatening syndrome triggered in susceptible indi-
viduals by volatile general anesthetics, depolarizing neuromus-
cular blocking agents, and heat stress (2). An MH episode is
characterized by increased expired CO2, rapid onset of meta-
bolic acidosis, elevated core temperature, and sustainedmuscle
contraction. Such episodes are often associated with ventricu-
lar tachycardia and cardiac arrest. The prevalence of MH has
been estimated as 1 in 10,000 anesthetic procedures; however,
this is likely to be an underestimate of MH susceptibility in the
general population, which has been estimated as high as 1:2,000
(3–5).
Although seven genomic loci have been linked to the disor-
der (6, 7), mutations in only two skeletal muscle proteins have
been confirmed to conferMH susceptibility. At least 250muta-
tions within the RYR1 locus (19q13.1) that encodes for the type
1 ryanodine receptor (RYR1), a Ca2 channel that localizes
within skeletal muscle junctional sarcoplasmic reticulum (SR),
have been associated with human MH susceptibility (4, 8–10).
RYR1 mutations currently account for more than 50% of the
families identified (4). More recently, a small number of muta-
tions in CACNA1S (1q32) that encode for the pore-forming
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subunit (CaV1.1; 1sDHPR) of the L-type voltage-dependent
Ca2 channels that localize within the skeletal muscle T-tubule
membrane were also confirmed to confer MH susceptibility.
Confirmed cases include three families with R1086H (11, 12),
one family with R1086S (13), and another with the R174W
mutation (14). One theory currently being tested is that MH
mutations in either CaV1.1 or RYR1 alter the fidelity of bidirec-
tional signaling across T-tubule SR junctions that is essential
for normal skeletal muscle excitation-contraction (EC) cou-
pling (15) and regulation of SR Ca2 leak (16).
Knock-in mice heterozygous (Het) for missense mutation
R163C-RYR1 (17) or Y522S-RYR1 (18), two of the more com-
mon mutations conferring MH susceptibility in humans,
exhibit fulminant MH when exposed to either an inhaled vola-
tile general anesthetic (e.g. halothane) or heat stress. Homozy-
gous (Hom)R163C-RYR1 andY522S-RYR1mice are not viable,
whereas their Het counterparts maintain MH susceptibility
throughout a normal life span. Both mouse models have con-
tributed valuable information about howN-terminalmutations
affect basal RYR1 channel dysfunction and alter pharmacolog-
ical responses of intact muscle cells (19, 20). Y522S-RYR1mice
show temporal development of skeletal muscle lesions resem-
bling central core disease in humans (21), whereas Het R163C-
RYR1 mice appear to have minimal muscle pathology.4 These
observations in mice are not consistent with clinical evidence
indicating that both analogous mutations cause MH suscepti-
bility in humans and that both are associated with central core
disease, although the onset and patterns of muscle damage can
differ (7, 22). Importantly muscle cells expressing either RYR1
mutation led to three fundamentally important findings about
MH susceptibility: 1) both show evidence of altered patterns of
bidirectional signaling between CaV1.1 and RYR1, with activa-
tion of L-type Ca2 current shifted to more negative potentials
(23–25); 2) both have chronically elevated cytoplasmic resting
Ca2 measured both in vitro (26) and in vivo (19, 27); and 3)
both have basal alterations in mitochondrial functions that
increase production of reactive oxygen species (20, 28). Why
Y522S-RYR1 and R163C promote different patterns of skeletal
muscle damage is not understood.
Recently, we completed phenotyping a new MHS mouse
expressing a mutation within the C-terminal region of RYR1,
T4826I-RYR1 (1), a mutation first described in a New Zealand
Maori pedigree withMH susceptibility but no clinical evidence
of central core disease (29). T4826I-RYR1 mice have several
notable phenotypic differences comparedwithmice expressing
N-terminal mutations. Both Het and Hom T4826I-RYR1 mice
survive to maturity and showmarked genotype and gender dif-
ferences in susceptibility to triggered MH with halothane
and/or heat stress throughout their life span. Electron micro-
graphic assessment of soleus indicates late onset alterations,
including abnormally distributed and enlarged mitochondria,
deeply infolded sarcolemma, and frequent z-line streaming
regions, which are more severe in males (1). Collectively, these
data indicate that the location of a mutation within the RYR1
sequence influences not only the penetrance and gender
dependence of MH susceptibility but also the patterns of basal
changes inmuscle bioenergetics and the progression and extent
of muscle damage.
Here we report a detailed analysis of basal functional differ-
ences in EC coupling and resting cytoplasmic Ca2 that confer
heightened sensitivity to halothane in single FDB fibers pre-
pared from Het and Hom T4826I-RYR1 knock-in mice and
how these differences relate to inherent biochemical and bio-
physical alterations in RYR1 Ca2 channels. We also find that
intactmyotubes derived from either Het orHomT4826I-RYR1
have altered oxygen consumption rates when compared with
WT.
EXPERIMENTAL PROCEDURES
Animals—WT, Het, and Hom skeletal muscle tissue, FDB
fibers, and myotubes were obtained from Het  Het crosses of
the T4826I-RYR1 knock-in mouse line (back-bred at least 10
generations to theC57BL/6 line) as described previously (1). All
cellular and biochemical experiments were performed from tis-
sues collected from mice whose genotype was determined by
PCR screening. The PCR primer sequences were as follows:
T4826I-RYR1 (forward), TTT GGA GAC ACG GAA ACA
GAA; T4826I-RYR1 (reverse), AGG GAG GTA CCT GGC
ACT CA; WT-RYR1 (forward), TCT CAC TGT CCA TAG
CTG; WT-RYR1 (reverse), ATC CAG CTT CTC CTA CAG.
All experiments on animals and collections of animal tissues for
the studies were conducted using protocols approved by the
institutional animal care and use committees at the University
of California at Davis.
Preparation of Primary Myotubes and Adult FDB Fibers—
Primary skeletal myoblast lines were isolated from newborn
WT mice or mice verified Het or Hom for T4826I-RYR1 as
described previously (30–32). Themyoblasts were expanded in
10-cm cell culture-treated Corning dishes coated with collagen
(Calbiochem) and were plated onto 96-well -clear plates
(Greiner) coated with Matrigel (BD Biosciences) for detection
of calpain or mitochondrial content or were alternatively
seeded onto proprietary 12-well plates for measuring oxygen
consumption (Seahorse Biosciences). Upon reaching 80%
confluence, growth factors were withdrawn, and the cells were
allowed to differentiate into myotubes over a period of 3 days
for these analyses (see below).
Flexor digitorum brevis (FDB) muscles were dissected from
male 3–6-month-oldmice verified by PCR asWT, Het or Hom
T4826I-RYR1 genotype. Single intactmyofibers were enzymat-
ically isolated as described previously (19, 33). In order to
reduce stress-activated SR Ca2 release during isolation, espe-
cially in T4826I-RYR1 fibers, 10 M dantrolene was included in
the initial dissociation medium. After isolation, the fibers were
plated on Matrigel-coated plates (BD Biosciences) and main-
tained in Dulbecco’s modified Eagle’s medium (Invitrogen)
supplementedwith 10% fetal bovine serum (ThermoFisher Sci-
entific, Waltham, MA) and 0.1 mg/ml penicillin-streptomycin
(Sigma) in the absence of dantrolene. Fibers were kept over-
night in a 5% CO2 incubator, and experiments were conducted
within 12–24 h of plating.
Ca2 Imaging—FDB fibers were loaded with Fluo-4/AM (10
M; 40 min at room temperature) in normal Ringer solution4 C. Franzini-Armstrong, personal communication.
Functional Abnormalities in Het and Hom T4826I-RYR1 MHS Muscle

















containing 146 mM NaCl, 4.7 mM KCl, 0.6 mM MgSO4, 6 mM
glucose, 25mMHEPES, 2mMCaCl2, and 0.02%PluronicF-127
(Invitrogen). The cells were thenwashed three timeswith Ring-
er’s solution and transferred to the stage of an IX71 inverted
microscope equippedwith a 40 0.9 numerical aperture objec-
tive (Olympus, Center Valley, PA) and illuminated at 494 nm to
excite Fluo-4 with a DeltaRam wavelength-selectable light
source. Fluorescence emission at 510 nm was captured from
individual fibers. Electrical field stimuli were applied using two
platinum electrodes fixed to opposite sides of the well and con-
nected to an A.M.P.I. Master 8 stimulator set at 4 V, 0.5-ms
bipolar pulse duration over a range of frequencies (1–20 Hz;
10-s pulse train duration). Fluo-4 fluorescence emission was
measured at 30 frames/s using a Cascade Evolve 512 camera
(Photometrics, Tucson, AZ). The images were acquired using
the Easy Ratio Pro software (PTI). The datawere analyzed using
Origin 7 software (OriginLab Corp.). Transients were normal-
ized to the florescence base line (Fo) of each individual fiber, and
the integrated area within the evoked responses was calculated
from the number of fibers indicated in the figure legend. Statis-
tical comparisons were performed with an unpaired t test.
In Vivo Recording of Vm and [Ca2]rest—Measurements were
performed on mice sedated with non-triggering ketamine/xy-
lazine (100/5 mg/kg), and core temperature was maintained
euthermic with an automated heating system (ATC1000WPI).
Once anesthesia was confirmed by a loss of tail pinch response,
micewere intubatedwith a tracheal cannula and connected to a
ventilator (Harvard Minivent, M-845, Holliston, MA) set at a
stroke volume of 200 l, 180 stokes/min, and ventilated with
medical air. Small incisions were made to expose the vastus
lateralis muscle of the left leg, and muscle fibers were impaled
with the double-barreled microelectrode as described previ-
ously (19). Potentials were recorded via a high impedance
amplifier (WPI FD-223, Sarasota, FL). The potential from the
3 M KCl barrel (Vm) was subtracted electronically fromVCaE, to
produce a differential Ca2-specific potential (VCa) that repre-
sents the [Ca2]rest. Vm and VCa were filtered (30–50 kHz) to
improve the signal/noise ratio and stored in a computer for
further analysis.
Halothane Exposure—Dissociated fibers were perfused with
0.1% (v/v) halothane freshly prepared in the imaging solution.
The halothane concentration was confirmed by mass spec-
trometry (23).
Seahorse XF-24 Metabolic Flux Analysis—Myoblasts were
cultured on Matrigel-coated Seahorse XF-24 plates (Seahorse
Biosciences) at a density of 30,000 cells/well using the same
procedure described above for Ca2 imaging experiments.
The oxygen consumption rate (OCR) and extracellular acidifi-
cation rate were evaluated after 3 days of differentiation. Before
the experiment, themyotubeswere equilibrated inDMEMsup-
plemented with 1 mM pyruvate and 1 mM GlutaMAX (running
medium) during 1 h at 37 °C. The oligomycin (10 g/ml final
concentration), FCCP (1M final concentration), and rotenone
(0.1 M final concentration) were dissolved in the running
medium. The respiratory capacity is defined like the OCR after
the FCCP addition. To compare the respiratory capacity among
the three genotypes, we calculated the area under the curve.
Values were normalized using the protein content of each well.
Mitochondria Content—Mitochondria content was quanti-
fied by staining myotubes with MitoTracker Green (Invitro-
gen), which preferentially accumulates inmitochondria regard-
less of the of the mitochondrial membrane potential and
provides an accurate assessment of total mitochondrial mass
(34, 35). Briefly, myotubes were loaded with 100 nM Mito-
Tracker Green for 30 min at 37 °C. The myotubes were
trypsinized and washed by centrifugation, and the associated
fluorescence was measured (excitation/emission 516/490 nm).
The fluorescence values were normalized using the protein
concentration.
CalpainActivity—The peptidase activity was evaluated using
the synthetic substrate tert-Boc-L-leucyl-L-methionine amide
(t-Boc) (Invitrogen) (36). Skeletal myotubes were loaded with
10 M t-Boc for 30 min at 37 °C. After cleavage by peptidases,
the product produces blue fluorescence with excitation and
emissionmaxima of351 and 430 nm, respectively. In order to
compare the fluorescence among the different genotypes, we
performed the assay using the Quantum View feature of an
Evolve 512 digital camera, permitting electron counting of each
pixel in the image. Measurements were captured from regions
of interest of identical size for each myotube, and the intensity
values were averaged for each genotype under identical illumi-
nation conditions on the same day.
Preparations of Membrane Fractions from Mouse Skeletal
Muscle—Skeletal muscles collected frommaleWT-RYR1, Het,
or Hom T4826I-RYR1 mice (2–3 animals/preparation, 3–6
months of age) were either prepared from freshly isolated tissue
or tissue flash-frozen and stored in liquid nitrogen and stored at
80 °C. Fresh tissue was minced on ice (frozen tissue was pul-
verized) and placed in ice-cold buffer containing 300 mM
sucrose, 5 mM imidazole, 0.1 mM PMSF, and 10 g/ml leupep-
tin, pH 7.4, and homogenized with three sequential bursts (30 s
each) of a PowerGen 700D (Fisher), at 9,000, 18,000, and 18,000
rpm. Homogenates were centrifuged at 10,000  g for 20 min.
Supernatants were saved, whereas the pellets were subjected to
a second round of homogenization and centrifugation at the
same settings described above. The remaining pellets were
discarded, and the supernatants were combined and poured
through four layers of cheesecloth. The filtrate was centri-
fuged at 110,000  g for 60 min at 4 °C. Pellets were resus-
pended in 300 mM sucrose, 10 mM Hepes, pH 7.4, aliquoted
into microcentrifuge tubes (100 l/sample), and either
stored at 80 °C for biochemical analyses or subjected to
further purification to obtain membranes enriched in junc-
tional SR as described previously by Saito et al. (37). Protein
concentration for each preparation was determined using
the DC protein assay kit (Bio-Rad).
Measurements of [3H]Ryanodine Binding—The apparent
association or equilibrium binding of [3H]ryanodine ([3H]Ry)
to RYR1-enriched membrane preparation (0.1–0.15 mg/ml)
was measured at 25 or 37 °C for 0–3 h with constant shaking in
buffer consisting of 2–5 nM [3H]Ry (PerkinElmer Life Sciences),
250 mM KCl, 20 mM HEPES, pH 7.4 (38), and defined free
[Ca2] as indicated in each specific experiment. Free Ca2 was
obtained by the addition of EGTA calculated according to the
software Bound-and-Determined (39). RYR1 channel modula-
tors Ca2 and/orMg2 were titrated in specific experiments as
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described in the figure legends.Nonspecific [3H]Ry bindingwas
determined in the presence of a 1,000-fold excess of unlabeled
ryanodine. Bound and free ligand were separated by rapid fil-
tration throughWhatman GF/B glass fiber filters using a Bran-
del cell harvester (Whatman, Gaithersburg, MD) with three
washeswith 5ml of ice-cold buffer (250mMKCl, 20mMHEPES,
15mMNaCl, and 50MCa2, pH 7.4). [3H]Ry retained in filters
was quantified by liquid scintillation spectrometry using a scin-
tillation counter (Beckman model 6500). Each experiment was
performed on at least two independent skeletal muscle prepa-
rations, each in triplicate. Linear or non-linear curve fitting was
performed using Origin software (Northampton, MA).
Measurements and Analyses of Single RYR1 Channels in
Bilayer Lipid Membrane (BLM)—Skeletal muscle membrane
preparation was used in order to induce fusion with the planar
BLM. BLM was formed by 30 mg/ml phosphatidylethanol-
amine/phosphatidylserine/phosphatidylcholine in decane (5:3:2
(w/w/w); Avanti Polar Lipids, Inc., Alabaster, AL). A 10-fold
Cs gradient was built from cis to trans (500 to 50 mM). The
recording baths were buffered to pH 7.4 by 20 mM Hepes. The
holding potential was held at 40 mV by bilayer clamp BC
525C (Warner Instruments, Hampden, CT) on the trans side,
where cis was virtually grounded. The cis chamber was where
membrane protein was added and thus was actually the cytoso-
lic face of the incorporated channel. The acquired current sig-
nals, filtered at 1 kHz (low pass Bessel Filter 8 Pole; Warner
Instruments) were digitized and acquired at a sampling rate of
10 kHz (Digidata 1320A, Molecular Devices (Sunnyvale, CA)).
All current recordings were made with Axoscope 10 software
(Molecular Devices) for at least 1 min under each defined
experimental condition. The channel open probability (Po),
mean open and closed dwell times (o and c), and current his-
tograms were calculated and obtained using Clampfit, pClamp
software version 10.0 (Molecular Devices). The number of
channels recorded under each condition was specified in the
respective figure legends. Differences in the WT-RYR1, Het,
and HomT4826I-RYR1 Po values were tested for statistical sig-
nificance using unpaired Student’s t tests.
Western Blotting—Skeletal muscle (genders either pooled or
separated by genotype) was homogenized, and crude mem-
brane fractions were prepared and denatured in SDS-PAGE
sample buffer (Bio-Rad) containing 5% 2-mercaptoethanol at
80 °C for 5 min. Protein (5, 10, or 15 g/lane) was loaded onto
Tris acetate 4–12% or 7% acrylamide gradient SDS-polyacryl-
amide gels (Invitrogen), electrophoresed, blotted onto PVDF,
labeled using secondary antibodies conjugated to infrared dyes
(emission 700 or 800 nm), and imaged using a LI-COR imager
as described previously (19). Total RYR1 was detected with
antibody 34C (40) at 1:1,000 dilution (Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City). Phospho-
epitope-specific antibody that recognizes mouse RYR1 Ser2844,
a PKA phosphorylation site (41), was purchased from Abcam
(ab59225) and used at 1:2,000 dilution. Band intensities of
RYR1 were normalized to glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) as a measure of total RYR1 protein, and
intensity of the Ser(P)2844-RYR1/total RYR1 ratio was analyzed
using Odyssey version 3.0 software. Protein phosphatase 1
(PP1; NewEngland Biolabs) was utilized to dephosphorylate SR
protein according to the vendor’s instructions. The reaction
mixture contained 50 mM HEPES, 100 mM NaCl, 2 mM DTT, 1
mM MnCl2, 0.01% Brij 35, pH 7.5, 4 mg/ml membrane protein
(WT, Het, and Hom T4826I-RYR1), and 200 units/ml PP1,
which was incubated at 30 °C for 10 min. Then the samples
were diluted into SDS-PAGE sample buffer for Western blot-
ting or into [3H]Ry binding buffer. [3H]Ry binding assay was
performed with 5 nM [3H]Ry, 1 M free Ca2, 100 g/ml pro-
teins in binding buffer containing 250 mM KCl and 20 mM
Hepes, pH 7.4, at 37 °C for 3 h.
RESULTS
T4826I-RYR1 FDB Fibers Display Enhanced Ca2 Transient
Properties and Heightened Sensitivity to Halothane—Differ-
ences in EC coupling in FDB fibers isolated frommaleWTmice
and knock-in Het or Hom T4826I-RYR1 were measured by
imaging electrically evoked Ca2 transients with Fluo-4. FDB
fibers were sequentially stimulated at frequencies ranging from
1 to 20Hz, and themagnitude of the Ca2 transients was quan-
tified as the integrated area of the response. Fig. 1A shows rep-
resentative traces of electrically evoked Ca2 transients mea-
sured inWT and HomT4826I-RYR1myotubes superimposed.
FIGURE 1. T4826I knock-in fibers display an enhanced frequency
response compared with the WT fibers. Fibers dissociated from WT-RYR1,
Het T4826I-RYR1, or Hom T4826I-RYR1 mice were loaded with Fluo-4 and
tested for electrically evoked EC coupling in the Ca2-replete external buffer
([Ca2]e  2 mM). A, representative responses of FDB to electrical pulse trains
applied at 1–20 Hz for a 10-s duration isolated from WT (black trace) and Hom
T4826I-RYR1 (gray trace) mice. For clarity, the Het T4826I-RYR1 trace is not
superimposed on the traces. B, summary data for all three genotypes relating
integrated areas of the Ca2 transient at each stimulus frequency. WT-RYR1
results are mean data  S.E. from n  162 fibers from five animals; Het results
are from n  180 fibers from three animals, and Hom results are from n  203
fibers from four animals. ***, p  0.001 compared with WT. **, p  0.01 com-
pared with WT. *, p  0.05 compared with WT.
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Compared with WT-RYR1, both Het and Hom T4826I-RYR1
FDB fibers consistently displayed accentuated responses to a
10-s pulse train of electrical stimuli 10 Hz. Hom, but not Het,
exhibited significantly larger Ca2 transients with pulses deliv-
ered at 20 Hz (Fig. 1B).
Fig. 2 shows three representative traces from each WT (A),
Het (B), and Hom (C) FDB fiber responding to electrical pulse
trains and subsequent responses to perfusion of 0.1% halo-
thane. Although perfusion of halothane had negligible influ-
ence on [Ca2]rest inWT, the anesthetic induced a pronounced
rise in [Ca2]rest in Het (92% responded, n  39 fibers tested)
and a much larger rise in Hom (100% response, n  31 fibers
tested) T4826I-RYR1 FDBs. The massive rise in [Ca2]rest
observedwithHomT4826I-RYR1 fibers exposed to continuous
halothane perfusion was invariably transitory and returned
toward the base line, whereas the rise in resting Ca2 was
FIGURE 2. Het and Hom T4826I-RYR1 FDB fibers show heightened sensitivity to halothane. Fibers dissociated from WT-RYR1 (A), Het T4826I-RYR1 (B), or
Hom T4826I-RYR1 (C) mice were loaded with Fluo-4 and tested for electrically evoked EC coupling in the Ca2 replete external buffer ([Ca2]e  2 mM). Fibers
were then challenged with halothane dissolved in the same external buffer ([Ca2]e  2 mM) in the absence of electrical stimuli. A–C, traces from individual
fibers from each genotype. Similar results were obtained from 39 and 28 Het and Hom fibers, respectively, from three independent fiber isolations for each
genotype. D, halothane can produce marked elevation in base-line Ca2 and regenerative Ca2 waves that were observed in eight of 28 Hom T4826I-RYR1
fibers tested. Oscillations abated, and the base line gradually was restored upon removal of halothane by perfusion. Halothane-triggered oscillations were not
observed in fibers isolated from either WT-RYR1 or Het T4826I-RYR1 mice.
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slower and sustained with Het T4826I-RYR1 fibers. In 29% of
the Hom T4826I-RYR1 fibers (eight fibers), halothane perfu-
sion initially induced a massive Ca2 rise that was followed by
regenerative Ca2 waves having a mean  S.D. frequency of
3.7  2.1 min1 (Fig. 2D and supplemental Movie 1). Neither
WT nor Het T4826I-RYR1 FDBs showed oscillatory behavior
in response to halothane (not shown). In the absence of halo-
thane, spontaneous Ca2 waves were not observed in 180 Het
and 203 Hom T4826I fibers analyzed.
To further evaluate the contribution of Ca2 entry to halo-
thane-triggered Ca2 dysregulation, we first verified the integ-
rity of electrically evoked EC coupling of Hom T4826I-RYR1
FDB fibers in the external solution repletewithCa2 ([Ca2]e  2
mM) and then exchanged the external solution with [Ca2]e 
0.1 mM in the presence of 0.1% halothane (Fig. 3A). Fig. 3B
shows that halothane-triggered peak elevation of myoplasmic
resting Ca2 is attenuated3.5-fold in [Ca2]e  0.1mM, indi-
cating that significant Ca2 entry contributes to the halothane
response in resting Hom T4826I-RYR1 FDB fibers.
Chronically Elevated Cytoplasmic [Ca2]rest in Adult
T4826I-RYR1 Fibers—We previously reported that RYR null
1B5 myotubes transduced with T4826I-RYR1 cDNA results in
significantly elevated [Ca2]rest compared with WT (42). Here
wemeasured [Ca2]rest in the vastus lateralis of ketamine/xyla-
zine-anesthetized WT, Het, and Hom T4826I-RYR1 mice
(results from both sexes combined). Compared with WTmus-
cles, in vivo microelectrode measurements showed that myo-
plasmic [Ca2]rest was 2.4- and 3.0-fold higher thanWT in Het
and Hom T4826I-RYR1 muscle fibers (mean  S.D. [Ca2]rest:
114  3.8, 278  21, and 337  20 nM, respectively, from n 
20–34 fibers/genotype; p  0.001 among the three genotypes).
In contrast to [Ca2]rest, the corresponding Vm of these vastus
lateralis fibers did not differ among the three genotypes (WT
82  1.3; n  20 from two mice; Het  82  1.4; n  34
from five mice; Hom  82  1.5; n  25 from three mice).
Collectively, these data indicate that adult FDB fibers isolated
fromHet andHomT4826I-RYR1mice exhibit heightened sen-
sitivity to halothane, whose magnitude is a function of gene
dose, consistent with their relative sensitivities to triggering
fulminantMH in vivo (1).Moreover, bothMH-susceptible gen-
otypes have two basal abnormalities: 1) enhanced gain of EC
coupling and 2) chronically elevated [Ca2]rest. We therefore
investigated if chronic dysregulation of cellular Ca2 dynamics
due to the T4826I-RYR1 mutation in the absence of triggering
agents affected mitochondrial bioenergetics and calpain activ-
ity, biomarkers known to mediate muscle damage.
Reduced Mitochondrial Respiration and Higher Calpain
Activities in Resting T4826I-RYR1 Myotubes—We tested if
T4826I-RYR1 mutations influenced OCR and respiratory
capacity (RC) in intact muscle cells using a Seahorse XF-24
metabolic flux analyzer. Technical challenges, including incon-
sistent plating density, precluded making these measurements
on FDB fibers; therefore, primary myotubes were used as an
alternative. Myotubes from all three genotypes were plated on
separate wells of a Seahorse plate at a density of 30,000 cells/
well and differentiated into myotubes for 3 days, at which time
OCR and RC were measured. In parallel cultures, MitoTracker
was used to measure mitochondrial mass. Fig. 4A shows a rep-
resentative OCR experiment performed on the three geno-
types. The OCR values are expressed as a percentage of the
respective base lines (before the addition of oligomycin). Both
Het and HomT4826I-RYR1myotubes displayed a significantly
lower basal OCR (p  0.001) compared withWT (Fig. 4B), and
basal OCR was significantly lower with Hom compared with
Het T4826I-RYR1myotubes (p  0.0167). In order to compare
RC across the three genotypes (OCR values after FCCP injec-
tion), the results were expressed as area under the curve (cor-
rected for non-mitochondrial rotenone-insensitive OCR). The
mean  S.E. respiratory capacities of Het and Hom T4826I-
RYR1 myotubes were significantly lower than that of WT (Fig.
4C). Interestingly, the Hom T4826I-RYR1 RC was higher than
that of Het (p  0.01).
MitoTracker green, a dye shown to bind mitochondria
regardless of membrane potential and a quantitative method
for measuring total mitochondrial mass (34, 35), was used to
test if the lower RC of the myotubes expressing T4826I-RyR1
was associated with altered mitochondrial content. Fig. 4D
shows that Het and Hom T4826I-RYR1 myotubes have signif-
icantly lower mitochondrial mass than WT myotubes (83.0 
1.9 and 67.5  6.6%, respectively).
t-BOC fluorescence was used to determine if chronically ele-
vated myoplasmic [Ca2]rest levels could promote calpain
FIGURE 3. [Ca2]e contributes to halothane-triggered peak Ca
2 rise in Hom T4826I-RYR1 FDB. Fibers dissociated from WT-RYR1 and Hom T4826I-RYR1
mice were loaded with Fluo-4 and tested for electrically evoked EC coupling in Ca2-replete external buffer ([Ca2]e  2 mM). Fibers were then challenged with
halothane in the same external buffer whose [Ca2]e was reduced with EGTA ([Ca
2]e  0.1 mM). A, representative traces from two individual Hom T4826I-RYR1
fibers. B, comparison of the halothane-triggered peak Ca2 amplitude (mean  S.E. (error bars)) for Hom T4826I-RYR1 fibers with [Ca2]e  2 mM (0.9  0.2; n 
8) and [Ca2]e  0.1 mM (3.7  0.7; n  4) (p  0.001).
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activities associated with muscle damage and degeneration
(43). Fig. 5 (left) shows representative micrographs, and bar
graphs (Fig. 5, right) show that both Het and Hom T4826I-
RYR1 myotubes have elevated calpain activities that are 170
and 145% of WT (mean t-BOC fluorescence of 100 myotubes/
genotype normalized to WT).
Expression and Phosphorylation of T4826I-RYR1 Channels
Do Not Account for Increased [3H]Ry Binding Capacity—The
influence of PKA phosphorylation of RyR1 on channel activity
has been debated in the literature (19, 41, 44, 45). Our recent
study of R163C-RYR1 isolated from Het mouse muscle indi-
cated higher Ser2844 phosphorylation (31%) compared with
FIGURE 4. Myotubes isolated from T4826I-RYR1 mice have impaired oxygen consumption and respiratory capacity and lower mitochondrial content.
The basal OCR and RC were evaluated before and after sequential injection of oligomycin, FCCP, and rotenone into the wells of a Seahorse Biosciences flux
analyzer. WT, Het, and Hom 4826I-RYR1 myoblasts were plated at 30,000 cells/well and differentiated to myotubes 3 days prior to measuring OCR and RC. A
representative experiment is shown in A, where OCR was measured simultaneously from the three genotypes before and after sequential injection of
mitochondrial inhibitors (oligomycin (O), FCCP (F), and rotenone (R)). Each trace represents the mean  S.E. (error bars) OCR of 5 wells/genotype. The values
were normalized to basal OCR (before oligomycin injection). B, mean  S.E. OCR obtained from 25 wells from four independent experiments, indicating that
Het and Hom T4826I-RYR1 myotubes have significantly lower basal OCR and RC compared with WT myotubes. The mean  S.E. basal OCR values were Het 
81.4  3.2 (p  0.01) and Hom  70.8  3.1% (p  0.01) of WT. C, RC measured as OCR after injecting FCCP to uncouple electron transport (after FCCP in A). The
mean  S.E. RC values were significantly lower in Het and Hom T4826I-RYR1 compared with WT (59.8  11.3% (p  0.034) and 64.8  8.7% (p  0.026),
respectively). D, intact myotubes were loaded with 100 nM MitoTracker Green, and the cellular fluorescence was quantitatively measured as described under
“Experimental Procedures.” The fluorescence values were normalized to protein concentration. Each bar represents the mean  S.E. of n  4 independent
experiments, each performed with five replicates. **, p  0.01; *, p  0.05.
FIGURE 5. T4826I mutants show enhanced intracellular calpain activity. A, myotube peptidase activity was measured quantitatively using the synthetic
substrate t-BOC, which is cleaved by intracellular calpain to a fluorescent product using Quantview as described under “Experimental Procedures.” B, calpain
activity summarized, where each bar represents the mean  S.E. (error bars) of 100 myotubes/genotype relative to WT (***, p  0.001).
Functional Abnormalities in Het and Hom T4826I-RYR1 MHS Muscle

















WT-RYR1, although dephosphorylationwith protein phospha-
tase did not restore R163C-RYR1 channel behavior to that
observed with WT-RYR1 channels (19). We therefore meas-
ured the level of total RYR1 expression and the degree of phos-
phorylation of Ser2844 (Ser(P)2844) in whole membrane frac-
tions from skeletal muscle prepared from WT, Het, and Hom
T4826I-RYR1. Fig. 6A shows results from a typical Western
blot of skeletal muscle membranes probed with monoclonal
antibody 34C that recognizes RYR1, indicating that no signifi-
cant differences were detected in the level of RYR1 protein
expression (normalized to GAPDH) among the three geno-
types, regardless of whether male and female muscle samples
were pooled or separated prior to preparing membranes for
Western blotting (Fig. 6A, left). Blots were probed with both
34C and an antibody that recognizes Ser(P)2844, which showed
that unlike in muscles expressing R163C-RYR1, there were no
significant differences among the three genotypes in the degree
to which RYR1 was phosphorylated (Fig. 6, B (top) and C (bar
plot of densitometry); n  16 blots from five different
preparations).
Het and Hom T4826I-RYR1 preparations display a signifi-
cantly higher capacity to specifically bind [3H]Ry than WT-
RYR1 preparations under defined assay conditions (Fig. 6B,
bottom), which is likely to reflect their inherently higher open
probabilities (see below). Although muscle preparations from
T4826I-RYR1 mice show similar levels of total RYR1 protein
and Ser(P)2844 as those fromWT, we determined if the level of
phosphorylation influences the capacity to bind [3H]Ry to a
greater extent in T4826I-RYR1 than WT by exposing mem-
brane preparations to PP1 (see “Experimental Procedures”).
Western blotting with and without PP1-treated membranes
showed nearly complete dephosphorylation of Ser(P)2844 in all
three genotypes (Fig. 6B, top), although the level of [3H]Ry
binding remained unchanged regardless of the degree of phos-
phorylation (Fig. 6B, bottom).
Het and Hom T4826I-RYR1 Channels Have Inherently
Higher Open Probability than WT—WT-RYR1, Het, or Hom
T4826-RYR1 channels were incorporated into BLMby induced
fusion of SR vesicles. In the presence of 1 M free cytosolic (cis)
Ca2, 2mMNa2ATP, and 100M free luminal (trans) Ca2, the
single channel activity was recorded at a holding potential of
40 mV (applied to trans). Fig. 7A shows representative cur-
rent traces from a WT-RYR1 (top trace), a Het (middle trace),
and a Hom (bottom trace) channel. Compared withWT-RYR1,
the Het T4826I-RYR1 channel exhibited 9-fold higher Po, with
2.5-fold greater o and 6-fold shortened o. Hom T4826-
RYR1 channels demonstrated even greater deviations com-
pared with WT-RYR1. For example, the Hom T4826-RYR1
shown in Fig. 7A displayed15-fold higher Po,5-fold greater
o, and 10.5-fold shortened o compared with WT-RYR1.
As shown in Fig. 7, B andC, channels reconstituted fromHet
T4826I-RYR1 mice produced more heterogeneous gating
behavior with a broadly scattered Po, ranging from 0.19 to 0.71
(mean Po  0.41; n  5; statistical analysis was not done due to
limited data points). This behavior would be expected from
random association of WT- and T4826I-RYR1 monomers into
functional tetramers as recently described for channels isolated
from Het R163C mice (19). Hom T4826-RYR1 channels
showed invariantly high Po behavior (mean Po  0.82; n  10),
which was significantly different from WT-RYR1 (mean Po 
0.10; n  12; p  0.0001).
Analyses of current amplitude distributions from represen-
tative channels reconstituted from each genotype are shown in
Fig. 8. The most frequent transitions of WT-RYR1 were cen-
tered about zero current, the closed channel state (top). In
marked contrast, the Hom T4826I-RYR1 channel (bottom)
exhibited most transitions centered about the maximal unitary
current amplitude, the full open channel state. Het T4826I-
RYR1 channels exhibited an intermediate and broader current
amplitude distribution compared with WT-RYR1 and Hom
T4826I-RYR1 channels (Fig. 8,middle).
FIGURE 6. No significant differences in total RYR1 expression or phospho-
rylation of Ser2844-RYR1 in preparations from WT, Het, or Hom T4826I-
RYR1 mice. A, representative Western blot showing the expression of RYR1
probed with monoclonal 34C (total RYR1; green channel). The bar graph
shows mean  S.E. (error bars) densitometry results for n  17 blots from
seven membrane preparations where muscle was pooled from males and
females. No differences among the three genotypes for total RYR1 protein
expression were detected. In separate preparations, skeletal muscle from
males and females were collected, and membranes prepared and blotted
separately. Bar graphs show mean  S.E. densitometry results for n  6 blots
from two separate membrane preparations. No differences between gender
or among genotypes for total RYR1 protein expression were detected. B, rep-
resentative Western blot showing Ser(P)2844-RYR1 levels before and after
treatment with PP1. The bottom panel summarizes the amount of specific
[3H]Ry binding to muscle membranes isolated from WT, Het, and Hom T4826I
mice with and without PP1 treatment. PP1 effectively dephosphorylates
Ser(P)2844-RYR1 but has no effect on [3H]Ry binding levels, which remain sig-
nificantly higher in preparations from Het and Hom mutants (also see Fig. 9).
C, densitometry shows that the relative levels of Ser(P)2844-RYR1/total RYR1
did not significantly differ among the three genotypes (mean  S.E. for n  16
blots from five membrane preparations) or between genders (mean  S.E. for
n  6 blots from two membrane preparations).
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T4826I-RYR1 Exhibits Altered Sensitivities to Regulation by
Ca2 and Mg2—Ca2 and Mg2 are physiological modula-
tors of RYR1 channel activity (46–48). Using [3H]Ry as a probe
to RYR1 channel conformational status, we investigated how
the T4826I-RYR1 mutation alters Ca2 regulation of [3H]Ry
binding through interactions with high affinity activation sites,
and both Ca2 and Mg2 interact with allosterically coupled
low affinity sites (49, 50). Fig. 9A shows the concentration-ef-
fect relationship across a range of Ca2 concentrations from
108 to 102 M. The maximum level of [3H]Ry binding at opti-
mal Ca2 was consistently 4- and 9-fold higher for Het and
Hom T4826I-RYR1 compared with WT, respectively (Fig. 9A,
left) (p  0.01). Analysis of the Ca2 curves normalized to their
respective maxima (Fig. 9A, right) revealed that both Het and
HomT4826I-RYR1 exhibit higher sensitivity toCa2 activating
at high affinity sites, but only Hom has reduced sensitivity to
Ca2 inhibition through low affinity sites (Fig. 9, A and C).
Interestingly, Hom and Het T4826I-RYR1 had reduced sensi-
tivity to Mg2 inhibition through low affinity sites compared
with WT (Fig. 9, B and D) (p  0.05).
Augmented Response of T4826I-RYR1 to Temperature—Ful-
minant MH can be triggered in Het and Hom T4826I-RYR1
mice in response to halothane and/or heat stress (1).We there-
fore investigated whether temperature differentially influences
the kinetics of [3H]Ry binding to skeletal muscle prepared from
the three genotypes. Fig. 10 shows that the observed rate of
[3H]Ry binding (kobs) depends significantly on genotype, with
the rank order Hom  Het  WT, and temperature (25 versus
37 °C) (A and B). Fig. 10C shows that the relative increase in
binding rate (normalized toWT) is greater at 37 °C than it is at
25 °C (Fig. 10C) and that Hom is more responsive to tempera-
ture than Het.
DISCUSSION
As is the case with most RYR1 MHS mutations, heterozygo-
sis for T4825I-RYR1 in humans is sufficient to conferMHS, and
individuals homozygous for T4826I-RYR1 have not been
described. Although very rare, individuals homozygous for
RYR1mutation C35R (51) and R614C (52) have been described
in families with a history of MHS, and muscle biopsies from
Hom individuals have increased sensitivity to halothane and
caffeine compared with Het individuals (52). Recently, we
described that Het and Hom T4826I-RYR1 mice are viable but
display distinctly different phenotypic penetrance for trigger-
ing fulminant MH with halothane and heat stress. This differ-
ence allowed us to uncover a genotype- and sex-dependent sus-
ceptibility to pharmacological and environmental stressors that
trigger fulminant MH and promote myopathy (1). In this
regard, T4826I-RYR1mice provide unique insights into under-
standing the genotype-phenotype relationships of MHS muta-
tions in vivo and the mechanisms influencing muscle dysfunc-
tion and fulminant MH in adult skeletal muscle in vivo and in
vitro.
One important outcome of channel dysfunction in adult
muscle fibers expressing T4826I-RYR1 is a chronically elevated
myoplasmic [Ca2]rest under basal (non-triggered) conditions.
In this regard, there is a clear gene dose influence on myoplas-
mic [Ca2]rest with WT  Het  Hom. Recently Murayama et
al. (53) did not detect a difference in cytoplasmic [Ca2]rest in
HEK 293 cells transiently transfected with T4826I-RYR1 com-
FIGURE 7. Hom T4826I-RYR1 channels are uniformly hyperactive in BLM. Single channels were incorporated in BLM in the presence of 1 M free Ca2, 2 mM
Na2ATP in cis chamber, 100 M Ca
2 in trans. A, representative 10-s continuous recording for a WT-RYR1 (top trace), a Het T4826I-RYR1 (middle trace), and Hom
T4826I-RYR1 channel currents (bottom trace) with their corresponding Po, o, and c. O, maximal single channel current amplitude. B and C, summary of Po data
for n  13 WT-RYR1, n  5 Het T4826I-RYR1, and n  10 Hom T4826I-RYR1 channels (B, scatter plot; C, mean  S.D. (error bars)). Channels were reconstituted
from three different paired skeletal muscle membrane preparations. ***, p  0.0001.
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pared with those expressing WT-RYR1. Several significant
methodological differences could account for these divergent
results. First, in vitro heterologous expression of RyRs in a sys-
tem where there are no DHPRs to provide negative regulation
versus measurements made in vivo in adult muscle fibers will
decrease any difference due to fact that increased numbers of
WT-RYR1 protomers will be in the leak conformation (16).
This is compounded by the use of Fura 2 ratios with the inher-
ent inaccuracy caused by using an EGTA-based buffer as an
indicator versus measurements of [Ca2]rest using calibrated
double barreled microelectrodes. Nevertheless, the present
results are consistent with those previously reported in adult
R163C-RYR1 Het muscle fibers (19) and indicate that chroni-
cally elevated [Ca2]rest may be a common outcome of MHS
mutations that promote RYR1 conformations that are leaky
(26).
Arguably, the most significant finding in the present study is
the uniformly high single channel Po and high capacity to bind
[3H]Ry of Hom T4826I-RYR1 preparations isolated from adult
mice when compared with WT. Although the unitary current
level and full gating transitions of HomT4826I-RYR1 channels
remain intact, the mutation concomitantly destabilizes the full
closed state and stabilizes the full open state of the channel to
achieve remarkably high Po with very tight current distribu-
tions, consistent with the formation of a uniform population of
T4826I-RYR1 tetramers. Channel gating behavior, rather than
differences in RYR1 protein expression or phosphorylation, is
responsible for the significantly higher level of [3H]Ry binding
observed in Hom muscle preparations when assayed in the
presence of optimal Ca2 and is achieved because the inher-
ently stable open channel conformation also stabilizes all
[3H]Ry binding sites in their high affinity conformation (54).
This interpretation is consistent with the fact that Het T4826I-
RYR1 channels display more heterogeneous gating behavior
consistent with random assembly of chimeric (WT/T4826I)
tetramers and achieve a [3H]Ry occupancy level intermediate
between those of WT and Hom. This behavior is similar to
those recently described for preparations isolated from Het
R163C-RYR1 MHS mice (19). Both Het R163C and T4826I
mutations enhance sensitivity to activation by Ca2 (3- and
2-fold compared with WT, respectively), but only the latter
mutation confers decreased sensitivity to inhibition byMg2 in
both Het and Hom preparations (1.5-fold compared with
WT) and a decreased sensitivity to Ca2 inactivation in the
Hom preparation. Cytoplasmic Mg2 is a physiological nega-
tive control of RYR1 channel activity under resting and activat-
ing conditions, and impaired regulation by Mg2 has been
implicated as an important contributor to MHS (42, 55–57).
However, the current results indicate that subtle shifts in regu-
lation by physiological cations cannot fully explain the pro-
found dysfunction of Het and Hom T4826I-RYR1 channels
observed here and may involve altered nitrosylation (20) or
other covalent modifications.
FIGURE 8. Het and Hom T4826I-RYR1 channels show distinct gating behaviors. Representative channel current amplitude histograms were obtained for
WT-RYR1, Het, and Hom T4826I-RYR1 under identical conditions described in the legend to Fig. 7. WT-RYR1 and T4826I-RYR1 channels show uniform current
amplitudes that strongly favor the closed and full open channel states, respectively. Het T4826I-RYR1 channels exhibited broader intermediate states consis-
tent with random association of WT-T4826I RYR1 monomers to form chimeric tetrameric channels. The insets show 1.5 s of representative current trace for each
genotype.
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Amore significant contributor to channel dysfunction is the
location of the mutation within the cytoplasmic loop linking
transmembrane segments 4 and 5 (S4-S5). Recently,Murayama
et al. (53) reported results of substitution scan of the N-termi-
nal half of the putative S4-S5 linker (Thr4825–Ser4829) of RYR1,
including T4825I (rabbit sequence). Consistent with our find-
FIGURE 9. WT, Het, and Hom T4826I-RYR1 differ in their modulation by Ca2 and Mg2. Equilibrium [3H]Ry binding (2 nM) was performed at 37 °C for 3 h
in the presence of defined [Ca2] (100 nM to 10 mM) (A) or 5 M Ca2  Mg2 (0 –30 mM) (B). EC50 and IC50 values obtained from curve fit of Ca
2 activation/
inactivation and Mg2 inhibition are plotted in C and D, respectively. The data are from 3– 4 different skeletal muscle membrane preparations (100 g/ml) (n 
9 –11 (A and C); n  8 –9 (B and D)). The significance of difference is denoted as follows: *, p  0.05; **, p  0.01.
FIGURE 10. WT, Het, and Hom T4826I-RYR1 differ in sensitivity to temperature. Initial binding of 5 nM [3H]Ry to 100 g/ml skeletal muscle membranes were
performed at 25 or 37 °C in the presence of 5 M free Ca2 and determined at 5, 10, 15, 20, 25, and 30 min. A, the results are plotted as rate lines. B, The initial
rates were calculated, and kobs values are plotted as bar graphs. C, the differences in kobs measured with Het and Hom T4826I-RYR1 are plotted relative to kobs
WT-RYR1. Statistical analyses indicate significant difference in temperature sensitivity among the three genotypes (***, p  0.001; n  4 from two different
skeletal muscle membrane preparations).
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ings with halothane in the current work and our finding of
increased sensitivity to caffeine and 4-CmC previously (42),
HEK 293 cells expressing T4825I-RYR1 exhibited higher sensi-
tivity to caffeine and produced higher Po channels reconsti-
tuted in BLM compared with those expressingWT (53). In this
regard, our results fromHomT4826I-RYR1 channels prepared
from adult skeletal muscle show even more profound stability
of the open state conformation (Po  0.8 in the presence of
suboptimal 1 M cytoplasmic Ca2) compared with expressed
T4825I-RYR1 (Po 0.3 in the presence of optimal 100 M cyto-
plasmic Ca2) (53).
Although qualitatively similar, several experimental differ-
ences could contribute to the quantitative divergence of our
single channel results from those of Murayama et al. (53), most
notable are the BLM solutions having pH of 7.4 versus 6.8, 1 M
versus 100M cis-Ca2, and trans-Ca2 of 100M versus unde-
fined, respectively. Our experimental conditions resulted in a
mean Po for reconstitutedWT channels of 0.12 (Fig. 7C), which
is lower than those reported by Murayama et al. (53) for WT
channels (mean Po 0.19). Nevertheless, our Hom T4826I-
RyR1 channels produced ameanPo of 0.81 (nearly 8-fold higher
than WT), whereas the T4825I-RyR1 channels reconstituted
from HEK 293 cells by Murayama et al. had a 1.5-fold higher
mean Po than WT (Po 0.19 for WT and Po 0.29 T4826I-
RyR1; Fig. 4B in Ref. 53). Interestingly, our BLM results are
consistent with both the 7–8-fold higher level of [3H]Ry bind-
ing reported in our study (Fig. 9A) and the 7–8-fold increase
reported byMurayama et al. at 100MCa2 (Fig. 5B in Ref. 53).
This distinction is important because it suggests that in addi-
tion to the inherent dysregulation imparted by the T4826I
mutation, the presence of themutation over time in the context
of its native muscle environment may lead to stable covalent
modifications, other than phosphorylation, that contribute to
abnormally active channel behavior, and these differences need
to be explored in the future.
As for the mechanism by which the T4826I mutation causes
RyR1 dysfunction, two possibilities are apparent: 1) impair-
ment of the strong negative feedback regulation provided by
protein-protein interactions within the junctional Ca2 release
unit, especially the DHPR (16), and 2) increased SR Ca2 leak,
possibly mediated by the RyR1 leak conformation (58). Muta-
tion of the -helical conformation of the S4-S5 linker may be
sufficient to impair both of these regulatory mechanism (53).
This hypothesis is reasonable given the important role of the
S4-S5 linker in gating other ion channels, such asKV1.2 (59, 60).
MHS mutations residing within the RYR1 N-terminal region
(amino acids 35–609) have been suggested to destabilize
domain-domain interactions (61, 62). However, it is clear from
the present study thatmutations residingwithin the transmem-
brane assembly are likely to disrupt channel gating through
distinct molecular mechanisms and underscore the allosteric
influence of RYR1 mutations that confer MHS.
Ca2 dysregulation triggered by acute halothane exposure of
FDB fibers from Het and Hom T4826I-RYR1 male mice is
clearly dependent on gene dose. A new finding is that the aug-
mented response to halothane seen in intact Hom FDB fibers
involves triggered release from SRCa2 stores and a significant
component of Ca2 entry. Thus, the fulminant MH syndrome
is likely to be initiated by disinhibition of RYR1 and exaggerated
Ca2 excitation-coupled Ca2 entry and store-operated Ca2
entry as suggested previously (19, 23, 61, 63). A better under-
standing of howMHSmutations impair coordinated regulation
of Ca2 release units may have novel therapeutic implications.
The fact that Hom T4826I-RYR1 mice survive without overt
clinical pathology, although consistent with the human condi-
tion when homozygosis has been identified (51, 52), raises sev-
eral fundamentally important issues about the remarkable dys-
function in their Ca2 release channels. In previous studies
with Het R163C MHS mice, RYR1 channel dysregulation was
associated with significantly reduced Ca2 transient ampli-
tudes evoked by electrical stimuli (i.e.ECcoupling) inmyotubes
but not adult FDB fibers (19). The difference in penetrance of
the R163C mutation in myotubes and FDB fibers was inter-
preted as an indication of tighter negative regulation of mutant
RYR1 channels within the context of more developed adult
junctions present in FDB compared with the peripheral junc-
tions found inmyotubes. Here we show that Het andHomFDB
fibers exhibit subtle differences in EC coupling responses
although significantly larger than those of WT, and the degree
of amplification is gene dose-dependent (Hom  Het). Thus,
the location and/or amino acid substitution of an MHS muta-
tion (R163C versus T4826I) influences the basal physiological
responses of adult fibers. More importantly, the viability of
Hom T4826I mice clearly indicates that the inherent dysfunc-
tion of RYR1 channelsmust be under extremely strong negative
regulation by the DHPR in the context of adult muscle fibers
because preferential targeting of WT channels to the junctions
is not possible. However, another consequence of the mutation
is to increase the vulnerability of disengaging negative regula-
tion of the RYR1 channel when exposed to triggering agents.
MHSmutations do produce adaptations that lead to chronic
elevations in cytoplasmic [Ca2]rest and reactive oxygen species
that are associated with bioenergetic adaptations in muscle
mitochondria (20, 28). Such adaptations may promote muscle
damagewhose rate of onset,morphologicalmanifestations, and
severity depend on the location of the mutation, zygosity, and
other factors, such as sex (1). Understanding the mechanisms
that limit andpromote fulminantMHand the potential damage
of highly dysfunctional MHS RYR1 channels is central to
understanding the etiology of this disorder.
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